| Id |
Subject |
Object |
Predicate |
Lexical cue |
db_id |
| 1812 |
10-19 |
ChemicalEntity |
denotes |
celecoxib |
MESH:C105934 |
| 1813 |
45-59 |
DiseaseOrPhenotypicFeature |
denotes |
skin reactions |
MESH:D003875 |
| 1814 |
63-76 |
ChemicalEntity |
denotes |
acetaminophen |
MESH:D000082 |
| 1815 |
78-89 |
ChemicalEntity |
denotes |
paracetamol |
MESH:D000082 |
| 1816 |
95-105 |
ChemicalEntity |
denotes |
nimesulide |
MESH:C012655 |
| 1817 |
136-173 |
ChemicalEntity |
denotes |
non-steroidal anti-inflammatory drugs |
MESH:D000894 |
| 1818 |
187-200 |
ChemicalEntity |
denotes |
Acetaminophen |
MESH:D000082 |
| 1819 |
202-213 |
ChemicalEntity |
denotes |
paracetamol |
MESH:D000082 |
| 1820 |
215-216 |
ChemicalEntity |
denotes |
P |
MESH:D000082 |
| 1821 |
222-232 |
ChemicalEntity |
denotes |
Nimesulide |
MESH:C012655 |
| 1822 |
234-235 |
ChemicalEntity |
denotes |
N |
MESH:C012655 |
| 1823 |
263-274 |
ChemicalEntity |
denotes |
antipyretic |
MESH:D058633 |
| 1824 |
275-298 |
ChemicalEntity |
denotes |
anti-inflammatory drugs |
MESH:D000893 |
| 1825 |
320-336 |
DiseaseOrPhenotypicFeature |
denotes |
hypersensitivity |
MESH:D004342 |
| 1826 |
397-434 |
ChemicalEntity |
denotes |
non-steroidal anti-inflammatory drugs |
MESH:D000894 |
| 1827 |
436-442 |
ChemicalEntity |
denotes |
NSAIDs |
MESH:D000894 |
| 1828 |
485-494 |
ChemicalEntity |
denotes |
Celecoxib |
MESH:C105934 |
| 1829 |
496-498 |
ChemicalEntity |
denotes |
CE |
MESH:C105934 |
| 1830 |
556-561 |
GeneOrGeneProduct |
denotes |
COX-2 |
NCBIGene:4513 |
| 1831 |
614-616 |
ChemicalEntity |
denotes |
CE |
MESH:C105934 |
| 1832 |
675-694 |
DiseaseOrPhenotypicFeature |
denotes |
cutaneous reactions |
MESH:D003875 |
| 1833 |
698-699 |
ChemicalEntity |
denotes |
P |
MESH:D000082 |
| 1834 |
704-705 |
ChemicalEntity |
denotes |
N |
MESH:C012655 |
| 1835 |
735-741 |
ChemicalEntity |
denotes |
NSAIDs |
MESH:D000894 |
| 1836 |
779-795 |
DiseaseOrPhenotypicFeature |
denotes |
hypersensitivity |
MESH:D004342 |
| 1837 |
799-800 |
ChemicalEntity |
denotes |
P |
MESH:D000082 |
| 1838 |
805-806 |
ChemicalEntity |
denotes |
N |
MESH:C012655 |
| 1839 |
855-861 |
ChemicalEntity |
denotes |
NSAIDs |
MESH:D000894 |
| 1840 |
880-881 |
ChemicalEntity |
denotes |
P |
MESH:D000082 |
| 1841 |
886-887 |
ChemicalEntity |
denotes |
N |
MESH:C012655 |
| 1842 |
896-910 |
DiseaseOrPhenotypicFeature |
denotes |
skin reactions |
MESH:D003875 |
| 1843 |
1064-1066 |
ChemicalEntity |
denotes |
CE |
MESH:C105934 |
| 1844 |
1363-1371 |
DiseaseOrPhenotypicFeature |
denotes |
erythema |
MESH:D004890 |
| 1845 |
1381-1390 |
DiseaseOrPhenotypicFeature |
denotes |
urticaria |
MESH:D014581 |
| 1846 |
1391-1401 |
DiseaseOrPhenotypicFeature |
denotes |
angioedema |
MESH:D000799 |
| 1847 |
1487-1489 |
ChemicalEntity |
denotes |
CE |
MESH:C105934 |
| 1848 |
1529-1539 |
DiseaseOrPhenotypicFeature |
denotes |
angioedema |
MESH:D000799 |
| 1849 |
1574-1590 |
DiseaseOrPhenotypicFeature |
denotes |
hypersensitivity |
MESH:D004342 |
| 1850 |
1603-1605 |
ChemicalEntity |
denotes |
CE |
MESH:C105934 |
| 1851 |
1629-1630 |
ChemicalEntity |
denotes |
P |
MESH:D000082 |
| 1852 |
1635-1636 |
ChemicalEntity |
denotes |
N |
MESH:C012655 |
| 1853 |
1644-1650 |
ChemicalEntity |
denotes |
NSAIDs |
MESH:D000894 |
| 1854 |
1695-1697 |
ChemicalEntity |
denotes |
CE |
MESH:C105934 |
| 1855 |
1774-1775 |
ChemicalEntity |
denotes |
P |
MESH:D000082 |
| 1856 |
1780-1781 |
ChemicalEntity |
denotes |
N |
MESH:C012655 |
